General Notices

• Request for Proposals (RFP) Notice: Blueprint MedTech (BPMT) Biocompatibility, Sterilization, and Animal Studies
  (NOT-DA-22-062)
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

• Update: iEdison to Transition from NIH eRA to NIST; Downtime and Action Items Required in Preparation for August 9 Launch of New iEdison
  (NOT-OD-22-158)
  National Institutes of Health
  

• Request for Proposals (RFP) Notice: Research and Development for Clinical Studies in the Blueprint MedTech (BPMT)
  (NOT-DA-22-063)
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

Notice of Changes to Funding Opportunities

• Notice to Extend Expiration Date for PAR-20-276: Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  (NOT-CA-22-092)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  

• Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Eligibility
  (NOT-TR-22-032)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish Funding Opportunity Announcements for Resource Centers for Minority Aging Research (RCMARs) and AD/ADRD RCMARs (P30 Clinical Trial Optional)
  (NOT-AG-22-023)
  National Institute on Aging
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
  (NOT-AG-22-024)
  National Institute on Aging
  

Notices of Special Interest

• Notice of Special Interest: Temporal Bone Histological Tissue Scanning Equipment Supplement
  (NOT-DC-22-009)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs
  (NOT-NS-23-001)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  

• Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity
  (NOT-OD-22-135)
  Office of Nutrition Research
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of AIDS Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Dietary Supplements
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Climate Change and Health Administrative Supplements
  (NOT-TW-22-003)
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  

Funding Opportunities

• Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
  (PAR-22-173)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2025
  
  

• Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
  (PAR-22-174)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2025
  
  

• Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
  (PAS-22-196)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 05, 2025
  
  

• Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
  (PAS-22-197)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 05, 2025
  
  

• Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
  (RFA-AG-23-033)
  National Institute on Aging
  Application Receipt Date(s): October 21, 2022
  
  

• Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed)
  (RFA-DA-23-017)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 18, 2022